Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Baxter International Inc (BAX)

Baxter International Inc (BAX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,075,664
  • Shares Outstanding, K 506,232
  • Annual Sales, $ 11,362 M
  • Annual Income, $ 1,001 M
  • 60-Month Beta 0.77
  • Price/Sales 3.62
  • Price/Cash Flow 16.34
  • Price/Book 5.04
Trade BAX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.73
  • Number of Estimates 10
  • High Estimate 0.76
  • Low Estimate 0.69
  • Prior Year N/A
  • Growth Rate Est. (year over year) -99.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.72 +5.17%
on 09/24/20
82.61 -1.05%
on 10/19/20
+1.49 (+1.86%)
since 09/21/20
3-Month
77.72 +5.17%
on 09/24/20
91.45 -10.62%
on 07/29/20
-6.93 (-7.82%)
since 07/21/20
52-Week
69.10 +18.29%
on 03/16/20
95.19 -14.13%
on 04/20/20
-6.71 (-7.59%)
since 10/21/19

Most Recent Stories

More News
Baxter Supports Findings of Ongoing COVID-19 Nutrition Study

The study, supported by Baxter (BAX) through an investigator-initiated grant, is the first analysis of longitudinal REE in critically ill, mechanically-ventilated COVID-19 patients.

BAX : 81.74 (+0.74%)
DVA : 89.61 (-0.10%)
BSX : 37.15 (-1.04%)
TMO : 468.76 (+0.75%)
Global Biomimetic Materials Market Report 2020-2025 with Profiles of Aortec, B. Braun, Baxter International, Exactech, Kyocera, and Terumo

The "Biomimetic Materials: Global Markets" report has been added to ResearchAndMarkets.com's offering.

BAX : 81.74 (+0.74%)
SmarTrend Watching for Potential Pullback in Shares of Baxter Intl Inc After 1.16% Gain

Baxter Intl Inc (NYSE:BAX) traded in a range yesterday that spanned from a low of $80.63 to a high of $82.31. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $81.34...

BAX : 81.74 (+0.74%)
Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care

Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, supports interim findings of an ongoing prospective study, "Persistent Hypermetabolism and Longitudinal Energy Expenditure in...

BAX : 81.74 (+0.74%)
Baxter to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference via webcast on Monday, November 9, 2020. Jay...

BAX : 81.74 (+0.74%)
Acute Kidney Injury Treatment Market Research Report by Type, by Treatment, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ -- Read the full report: The Global Acute Kidney Injury Treatment Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.04%.Market...

BAX : 81.74 (+0.74%)
MRK : 78.07 (-0.26%)
NVS : 84.14 (-1.81%)
Baxter Supports New Study Showing Nutritional Needs in Critically Ill COVID-19 Patients and Published Practical Guidelines for Care

Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, supports interim findings of an ongoing prospective study, "Persistent Hypermetabolism and Longitudinal Energy Expenditure in...

BAX : 81.74 (+0.74%)
Chronic Diseases Tend To Lead To Kidney Failure, Thus An Increase Drives The Dialysis Devices And Equipment Market

(Dialysis Devices And Equipment Companies Included: Fresenius Medical Care AG & Co. KGaA, Baxter International, Nikkiso Co. Ltd, DaVita Inc., B. Braun Avitum AG, NxStage Medical, Asahi Kasei Corporation,...

AHKSF : 9.0200 (+0.22%)
BAX : 81.74 (+0.74%)
DVA : 89.61 (-0.10%)
MDT : 109.23 (+0.07%)
NXTM : 30.00 (+0.03%)
TFX : 359.06 (-0.76%)
Global Vitiligo Treatment Market to Exhibit a CAGR of 5.8% and Touch USD 1,944.5 Million by 2026; Rise in the Research and Development Activities to Boost Growth, says Fortune Business Insights(TM)

Global vitiligo treatment market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to Fortune Business Insights, titled, "Vitiligo...

ALPMF : 14.5300 (-0.82%)
BAX : 81.74 (+0.74%)
INCY : 88.60 (-0.79%)
Baxter Intl Inc (BAX) Crosses Pivot Point Support at $80.81

Baxter Intl Inc (NYSE:BAX) has opened bearishly below the pivot of $81.42 today and has reached the first level of support at $80.81. Analysts will be watching for a cross of the next downside pivot targets...

BAX : 81.74 (+0.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare...

See More

Key Turning Points

2nd Resistance Point 83.03
1st Resistance Point 82.38
Last Price 81.74
1st Support Level 80.94
2nd Support Level 80.15

See More

52-Week High 95.19
Fibonacci 61.8% 85.22
Fibonacci 50% 82.15
Last Price 81.74
Fibonacci 38.2% 79.07
52-Week Low 69.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar